Tinnitus Retraining therapy Trial

The purpose of the Tinnitus Retraining Therapy Trial (TRTT) is to assess the efficacy of Tinnitus Retraining Therapy (TRT) as a treatment for severe debilitating tinnitus in a randomized trial. TRT is a non-medical intervention that uses directive counseling (DC) and sound therapy (ST) to habituate the patient’s associated negative emotional reactions to tinnitus, its perception, and ultimately, its impact on the patient’s life. Johns Hopkins is the Data Coordination Center (DCC) for this the Tinnitus Retraining Therapy Trial, which will test the efficacy of TRT as a therapy for severely debilitating tinnitus. The DCC will not screen nor have any direct contact with trial participants. Study forms will be keyed by the Clinical Centers into a web-based data management system that uses SSL encryption during transmission of data from Clinical Centers to the DCC. The study forms’ data transmitted by the Clinical Centers and received by the DCC are identified by name code and study I.D. only. There are no personal identifiers on these forms.